GleamWall
中文EN

RMTG Regenerative Medical Technology Group Inc.

Retail-Retail Stores, NEC · OTC · SEC CIK 1760026 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY94.3%
TTM net income YoY-155.5%
TTM EPS YoY-55.6%
Revenue 3-yr CAGR66.0%
Net income 3-yr CAGR—

Margins

Gross margin59.8%
Operating margin0.5%
Net margin-101.2%
FCF margin-6.2%
EBITDA margin4.3%

Returns

ROE—
ROA-184.4%
ROIC (approx.)—
Asset turnover1.82x

Leverage & solvency

Liabilities / assets771.0%
Debt / equity—
Current ratio0.05x
Interest coverage0.00x

Cash quality & payout

Operating cash flow / net income-0.03x
Accruals ratio-189.6%
Payout ratio—
Capex / revenue9.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-312024Q32024-09-30
Income statement
Revenue$4.02M$2.64M$1.57M$1.18M$983,318$1.36M$1.51M$986,308
Cost of revenue$1.44M$872,862$792,427$678,977$397,686$420,447$530,640$239,247
Gross profit$2.58M$1.77M$779,495$501,557$585,632$943,894$980,183$747,061
SG&A expense$619,164$475,812$389,318$277,696$207,449$245,566$113,111$264,078
Operating income$565,977$229,783-$306,274-$445,761-$250,087$134,960$380,618$19,648
Interest expense$2.23M$2.19M$2.01M$3.49M$1.06M$895,850$1.02M$905,572
Net income-$2.91M-$876,274-$1.39M-$4.35M-$1.44M-$760,039-$638,186-$887,146
EBITDA$656,787$327,477-$207,931-$369,683-$195,255$186,774$352,806$108,476
EPS (basic)-0.22-0.07—-0.35-0.12-0.06—-0.07
EPS (diluted)-0.22-0.07—-0.35-0.12-0.06—-0.07
Weighted avg. shares (diluted)13.22M13.14M—12.54M12.54M12.54M—12.54M
Balance sheet
Cash & equivalents$1.32M$1.06M$956,718$1.19M$1.61M$1.22M$1.17M$836,427
Receivables$110,244$34,821$43,815$114,006$36,676$16,306$22,605—
Inventory$481,168$298,201$159,277$155,886$105,688$22,829$10,115—
Current assets$2.28M$1.57M$1.22M$1.51M$1.91M$1.45M$1.25M—
PP&E, net$1.09M$1.11M$870,759$677,544$504,409$424,274$451,703—
Goodwill$1.68M$1.68M$1.68M$1.68M$1.68M$1.68M$1.68M—
Intangibles$12,694$37,079$61,464$85,849$110,234$134,619$159,004—
Total assets$5.85M$5.01M$4.49M$4.52M$4.49M$3.98M$3.82M—
Current liabilities$42.61M$38.20M$38.13M$17.27M$30.54M$29.88M$28.97M—
Total liabilities$45.11M$40.63M$40.54M$34.57M$33.51M$32.10M$31.18M—
Shareholders' equity-$39.26M-$36.36M-$36.05M-$30.05M-$29.02M-$28.12M-$27.36M-$26.72M
Shares outstanding13.74M13.14M13.14M12.54M12.54M12.54M12.54M—
Cash flow statement
Operating cash flow$331,974$102,124$38,196-$203,731-$598,093$57,109$379,393$272,942
Capital expenditure$43,499$315,394$267,172$224,829——$50,000$53,608
Free cash flow$288,475-$213,270-$228,976-$428,560——$329,393$219,334
Investing cash flow-$43,499-$315,394-$267,172-$224,829——-$50,000-$53,608
Financing cash flow-$26,619$318,000$0$0————
Depreciation & amortization$90,810$97,694$98,343$76,078$54,832$51,814-$27,812$88,828

Free plan shows the latest 8 periods; Pro shows all 34 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.